Question 1

Am I eligible for this trial based on my current medications and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this treatment affect my current diabetes management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any side effects I should be aware of with aleglitazar?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my participation in this trial impact my visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril clinical trial (NCT01398267). Contact the study team or your healthcare provider for specific answers.

What this study is about